Bavarian Nordic HERA Update: 750,000 Doses of Mpox Vaccine Secured for 2026

Bavarian Nordic, HERA framework, mpox vaccine, smallpox vaccine, vaccine procurement, European Commission, BARDA, public health preparedness, vaccine orders, DKK 1.5-2 billion business.
Dive into the latest clarification from Bavarian Nordic on their HERA framework agreement with the European Commission's Health Emergency Preparedness and Response Authority. Learn about the new order for 750,000 doses of MVA-BN smallpox/mpox vaccine set for delivery in 2026, following a BARDA contract from the US. Explore how this builds their public preparedness business, with potential for more orders and a revenue target of DKK 1.5-2 billion next year. Discover Bavarian Nordic's role as a leading supplier of mpox and smallpox vaccines, plus their innovative travel vaccine portfolio, all aimed at enhancing global health security.